GE Healthcare GmbH
Pharmaceutical Companies · München
GE Healthcare GmbH is the German subsidiary of GE HealthCare Technologies, based in Solingen. The company offers medical imaging technologies (MRI, CT, ultrasound), diagnostics and digital solutions for healthcare.
Content in German
The detailed company information on this page is provided in the original German language. You can use your browser's built-in translation feature to view it in English.
Right-click on the page and select "Translate to English" or use the translation icon in your browser's address bar.
GE Healthcare GmbH Address & Contact
Company profile
2023
Founded
50.000+
Employees
GE Healthcare GmbH Overview
GE Healthcare GmbH is the German subsidiary of GE HealthCare Technologies Inc., a globally leading provider of medical technology, imaging systems, diagnostics, and health IT solutions. GE HealthCare emerged in 2023 from the spin-off of General Electric (GE) and has since operated as an independent company listed on NASDAQ. GE HealthCare employs approximately 50,000 people worldwide and generates annual revenue of around 19 billion US dollars. The German branch is headquartered in Munich (Bavaria) and serves clinics, hospitals, and radiology practices in Germany.
Field of Activity & Products
GE Healthcare is primarily engaged in medical imaging in Germany. The portfolio includes modern CT systems, especially the Revolution series, which stands out for its high image quality and usability in emergency medicine. This also includes MRI devices of the SIGNA series, known not only for their image accuracy but also for their patient-friendly design solutions that enhance comfort during examinations.
In the ultrasound sector, GE Healthcare offers specialized systems for cardiology, obstetrics, anesthesia, and general radiology. These technologies enable precise diagnoses and are particularly significant in early diagnosis. Additionally, the offering includes PET/CT scanners for nuclear medicine and oncology, as well as advanced X-ray systems that perform excellently in interventional radiology and fluoroscopy.
In the area of diagnostics (Life Sciences), GE Healthcare offers novel radioactive contrast agents that provide an improved molecular imaging solution for nuclear medical diagnostics. In the fast-paced and ever-changing world of medical IT and patient monitoring, GE Healthcare implements advanced AI-supported systems such as the Edison platform, aimed at optimizing clinic operations and streamlining workflows through automated image interpretation.
History & Regulation
GE Healthcare has a history of over 100 years in medical imaging. The first X-ray technologies for hospitals were developed in the early years of the company and have continually evolved over the decades. This long tradition has enabled GE Healthcare to build outstanding expertise in medical technology that meets today's standards of quality and innovation.
All medical products sold by GE Healthcare in Germany are subject to the strict requirements of the EU Medical Device Regulation (EU-MDR) and the regulations of the U.S. Food and Drug Administration (FDA). By adhering to these, the company ensures the safety and reliability of its products.
GE HealthCare is also an active member of the German Medical Technology Association (BVMed), highlighting the importance of regulation and standardization within the industry. This membership allows GE Healthcare to actively participate in the development of standards and guidelines that ensure quality and safety in medical technology.
Regional Importance and Special Features
GE Healthcare GmbH plays a significant role not only internationally but also regionally in Bavaria and beyond in Germany. Munich offers numerous advantages as a location, such as proximity to leading research institutions and universities, fostering collaboration in the innovation and development of new technologies.
The specific focus on imaging procedures highlights GE Healthcare's ongoing relevance in the medical sector, particularly in light of the advancing digitalization of the healthcare industry. Through its continuous investments in research and development, the company significantly contributes to improving patient care and efficiency in healthcare.
In developing new products and solutions, GE Healthcare is committed to aligning with the needs of users. This includes continuous training of professionals in clinics to optimally utilize the technology. This demonstrates GE Healthcare's long-term commitment to promoting healthcare in Germany.
More information: Pharmaceutical companies in Bavaria or all pharmaceutical companies in Germany on Sanoliste.
Frequently asked questions about GE Healthcare GmbH
What does GE Healthcare GmbH do?
Die GE Healthcare GmbH stellt medizintechnische Geräte zur Diagnostik her and liefert dazu Daten, Analysen and Anwendungen with verschiedenen Dienstleisungen. Ihre Fachbereiche are Kardiologie, Onkologie, Radiologie and Nuklearmedizin sowie Lösungen at Schlaganfall. Außerdem offers sie Veranstaltungen and Trainings rand um the Thema „Diagnostische Bildgebung“.
More Pharmaceutical Companies in München
Pharmaceutical Companies in Germany
Related areas in healthcare
Pharmaceutical Companies by location
About Pharmaceutical Companies
Germany is one of the world's leading pharmaceutical nations, home to more than 1,000 pharmaceutical businesses employing approximately 130,000 people (vfa 2023). Companies operating in this sector develop, manufacture and distribute medicines across the entire value chain, from early-stage research and clinical trials through to market authorisation and commercial distribution. In Germany, every manufacturer of medicinal products must hold a manufacturing authorisation (Herstellungserlaubnis) issued under Section 13 of the AMG (Arzneimittelgesetz, Germany's Medicinal Products Act). Medicines may only be placed on the market after receiving approval from either BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte, Germany's Federal Institute for Drugs and Medical Devices, broadly comparable to the FDA in the United States or the MHRA in the United Kingdom) or the European Medicines Agency (EMA) via the centralised procedure. All manufacturing sites are subject to regular GMP (Good Manufacturing Practice) inspections carried out by the competent pharmaceutical supervisory authority of the relevant German federal state. The sector covers prescription-only medicines (Rx), non-prescription OTC products, generics, biosimilars and active pharmaceutical ingredients (APIs). This directory lists pharmaceutical manufacturers, marketers and licence holders across all German federal states with full contact details, addresses and phone numbers.
Germany's Pharmaceutical Industry
Germany is consistently ranked among the top five pharmaceutical markets worldwide, generating annual revenues exceeding EUR 50 billion and accounting for the largest share of pharmaceutical production in continental Europe. The industry is represented by two major associations: vfa (Verband Forschender Arzneimittelhersteller), which represents research-based companies, and BAH (Bundesverband der Arzneimittel-Hersteller), which represents the broader manufacturer base including OTC and self-medication products. German pharmaceutical companies cover the full spectrum from global innovator corporations and mid-sized specialty manufacturers to generic producers and biotech firms. The country is a world leader in active pharmaceutical ingredient (API) production, biologics manufacturing and pharmaceutical chemistry. Key therapeutic areas of strength include oncology, cardiovascular medicine, immunology, neuroscience and rare diseases. Germany also serves as a significant export hub, with pharmaceutical products among the country's leading export categories. The sector benefits from a highly skilled workforce, world-class university research institutions and a dense network of research hospitals (Universitätsklinika) that facilitate clinical trial activity.
Regulatory Framework: BfArM, EMA and the AMG
The legal foundation for pharmaceutical activity in Germany is the Arzneimittelgesetz (AMG, German Medicinal Products Act), which regulates the authorisation, manufacture, import, distribution, labelling and pharmacovigilance of medicinal products. For English-speaking readers unfamiliar with the German regulatory landscape: BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte) is the national competent authority responsible for approving medicines marketed only in Germany, supervising narcotics, and maintaining the pharmacovigilance database. BfArM is a higher federal authority (Bundesoberbehörde) subordinate to the Federal Ministry of Health (Bundesministerium für Gesundheit). For medicines approved via the centralised EU procedure, the European Medicines Agency (EMA) grants a single marketing authorisation valid in all 27 EU member states. Germany is also home to the Paul-Ehrlich-Institut (PEI), a second federal authority that specifically handles biological medicines including vaccines, blood products and gene therapy products. Manufacturing sites are inspected by state-level pharmaceutical supervisory authorities (Landesbehörden) to verify GMP compliance, with findings entered into the EudraGMDP database operated by the EMA.
Regional Pharmaceutical Clusters in Germany
Germany's pharmaceutical industry is geographically distributed across several major regional clusters. The Rhine-Main area around Frankfurt and Leverkusen in North Rhine-Westphalia is home to some of Germany's largest pharmaceutical sites, including facilities belonging to global corporations with long histories in German chemistry and pharmaceuticals. Bavaria (particularly Munich, Penzberg and Marburg) is a second major hub, especially strong in biotechnology and biologics production. Baden-Württemberg, including cities such as Mannheim, Heidelberg and Biberach an der Riss, is home to several significant research-based manufacturers. Hamburg and the northern German region have a cluster of specialty and generic manufacturers. Berlin has a growing biotech scene connected to its research universities and the Charité hospital. Hesse is notable for its proximity to Frankfurt's logistics infrastructure and several major API manufacturers. Smaller but significant clusters exist in Saxony (Leipzig, Dresden) and Lower Saxony, benefiting from proximity to university research centres and historically established chemical industry sites.
Drug Classes and Product Segments
German pharmaceutical companies cover all major drug classes. Prescription (Rx) products account for the largest share of revenue; generics manufacturers such as Stada, ratiopharm (Teva) and Hexal produce chemically equivalent alternatives after patent expiry, significantly reducing costs for the healthcare system. Biologics and biosimilars are gaining ground rapidly: monoclonal antibodies, insulin analogues and recombinant growth factors require specialised biotech manufacturing facilities. OTC products (over-the-counter), i.e. medicines available without a prescription, represent a multi-billion-euro market served by companies such as Bayer Consumer Health, Stada and Klosterfrau. Homeopathic preparations, herbal medicines and dietary supplements form further regulated segments. Digitalisation is increasingly shaping the sector: Digital Health Applications (DiGA) have been reimbursable since 2020, and AI-assisted drug development is significantly shortening time-to-market.
What does a pharmaceutical company do?
Pharmaceutical companies develop, produce and distribute medicines. They cover the entire value chain from research and clinical trials through to market launch and distribution. In Germany, they are supervised by BfArM (the Federal Institute for Drugs and Medical Devices, comparable to the FDA or MHRA).
How are pharmaceutical companies regulated in Germany?
Pharmaceutical companies in Germany must hold a manufacturing authorisation under Section 13 of the AMG (German Medicinal Products Act). All authorised medicines require approval from either BfArM or the European Medicines Agency (EMA). Regular GMP (Good Manufacturing Practice) inspections ensure quality standards are maintained.
Where can I find contact details for pharmaceutical companies in Germany?
Industry associations such as vfa (Association of Research-Based Pharmaceutical Companies) and BPI (Federal Association of the German Pharmaceutical Industry) maintain member directories. Many companies also list their key contacts directly on their websites. Sanoliste provides a searchable directory of pharmaceutical companies in Germany sorted by federal state and city.
How many pharmaceutical companies are there in Germany?
Germany is home to more than 1,000 pharmaceutical companies employing approximately 130,000 people, according to vfa (the Association of Research-Based Pharmaceutical Companies) 2023 data. The sector includes multinational corporations, mid-sized specialty firms, generic manufacturers and biotech startups.
What is BfArM and what does it regulate?
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte) is Germany's Federal Institute for Drugs and Medical Devices. It is a higher federal authority within the portfolio of the Federal Ministry of Health and is responsible for approving medicines for the German market, monitoring drug safety (pharmacovigilance), regulating narcotics and controlled substances, and overseeing medical devices in Germany. It is broadly comparable to the FDA in the United States or the MHRA in the United Kingdom.
What is the difference between BfArM approval and EMA approval?
Medicines in Germany can be approved through two main routes. BfArM grants national marketing authorisations valid in Germany, or decentralised and mutual recognition procedure approvals valid in multiple EU states. The EMA (European Medicines Agency) grants centralised marketing authorisations valid in all 27 EU member states simultaneously, typically used for innovative biologic medicines, oncology drugs and products for rare diseases.
What does GMP mean in the context of German pharmaceutical manufacturing?
GMP stands for Good Manufacturing Practice. In Germany and the EU, GMP compliance is a legal requirement for all pharmaceutical manufacturers under the AMG and the EU GMP Guidelines (EudraLex Volume 4). GMP covers all aspects of production including premises, equipment, personnel qualification, process validation, documentation and quality control. Compliance is verified by regular inspections from the competent state pharmaceutical supervisory authority.